BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile


Inclinix, Inc. 

Corporate Headquarters
3534 South College Road, Suite F

Wilmington, North Carolina 28412, USA

R&D Headquarters
209 West Street, Suite 301

Annapolis  Maryland  21401  U.S.A.
Phone: 910-395-5674 Fax: 910-392-7275


Inclinix, Inc. provides productive investigative sites and qualified clinical research study participants to pharmaceutical, biotech, and medical device companies on a performance basis. Headquartered in Wilmington, North Carolina, Inclinix services are offered globally with project staff based in the United States, Sweden, and the United Kingdom. Inclinix has screened approximately two million patients, and has forged relationships with over 150,000 clinical investigators. Sponsors and CRO partners benefit from eleven years of experience in global clinical research with the successful completion of 400 trials in 130 indications.

Inclinix’s proprietary process for developing Enrollment-Ready Sites, supported by Performance Enrollment outreach strategies and leading-edge technology solutions, meet the challenge of clinical development from feasibility through subject compliance.

Clinical Enrollment Managers (CEMs) are in-field enrollment experts highly educated on each protocol to evaluate, train and prepare each site for Enrollment-Ready Certification

• Customized Performance Enrollment strategies include CEM site-based and community outreach, traditional media and online marketing to expand the enrollment environment and deliver qualified enrolled subjects

Critical Population Research® (CPR), quantitative evaluative technology for Site Selection and Patient Recruitment, allows Inclinix to analyze complex databases to identify optimal geographic areas where patient population meets protocol inclusion/exclusion criteria.

In-house advertising agency delivers award-winning integrated recruitment and retention campaigns that include media planning and buying, online communications, printed collateral, site support materials and social marketing.

TeleMEDICINE™ Contact Center staffs medically-trained, multi-lingual Case Managers, that conduct screening, appointment-setting, reminder and follow-up calls to guarantee interested candidates are converted into qualified study participants.

• Innovative Patient Education, Retention and Compliance tools include the Inclinix Patient Passport™, SMS Text Patient Communications, and the Patient Education System to ensure that subjects remain compliant and complete each study.


Enrollment Feasibility

Investigator Recruitment
• Regulatory Document Management
• Investigator/Site Assessment and Selection
• Investigator/Site Education

Site Support Tools
• Enrollment Tools
• Retention Support

Patient Recruitment
Community Outreach
Direct-to-Patient Outreach
• Advertising & Design
• Online Outreach
• Medical Screening & Referral
• Educational Programs

Retention Programs
• Patient Retention
• Patient Compliance
• Investigator/Site Retention

 Key Statistics

Ownership: Private

Web Site: Inclinix, Inc.


 Company News
Inclinix, Inc. and JSW Life Sciences Announce Formal Strategic Partnership for European Clinical Trial Enrollment 2/21/2012 10:53:32 AM
DATATRAK International, Inc. (DATA) Forms Strategic Partnership with Inclinix, Inc. 5/1/2009 9:39:25 AM
Intercell AG Partners with Inclinix, Inc. to Enroll 1800 Volunteers for Phase III Travelers' Diarrhea Vaccine Study 1/20/2009 8:24:54 AM
Inclinix, Inc. Releases Next Generation Critical Population Research(R) (CPR) for Clinical Trial Investigator Site Selection and Patient Recruitment 1/14/2009 8:43:53 AM
Inclinix, Inc. Announces Expansion of Regional Recruitment Manager Enrollment Support Team 10/15/2008 11:55:50 AM
Inclinix, Inc. Expansion Creates New Position and Promotions 6/4/2008 12:06:10 PM
Inclinix, Inc. Announces New Patent for Expert System Platform 3/11/2008 9:57:48 AM
Inclinix, Inc. Announces Executive Management Team Changes 2/22/2008 11:33:13 AM
Inclinix, Inc. Secures $10 Million in Expansion Funding 1/10/2008 11:46:30 AM
Inclinix, Inc. Secures $10 Million in Expansion Funding 1/7/2008 7:31:45 AM